메뉴 건너뛰기




Volumn 7, Issue 2, 2008, Pages 119-128

The treatment targets of asthma: From laboratory to clinic

Author keywords

Airway inflammaton; Asthma; Common therapy; New targets; Remodelling

Indexed keywords

AL 438; ALTRAKINCEPT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CELL ADHESION MOLECULE; CHEMOKINE; CICLESONIDE; CILOMILAST; CORTICOSTEROID; CYTOKINE; CYTOKINE ANTIBODY; ETANERCEPT; FORMOTEROL; GLUCOCORTICOID; LUMILIXIMAB; MEPOLIZUMAB; MONTELUKAST; OMALIZUMAB; PASCOLIZUMAB; PHOSPHODIESTERASE INHIBITOR; PLACEBO; PRANLUKAST; QUINOLONE DERIVATIVE; RESLIZUMAB; ROFLUMILAST; SALBUTAMOL; SALMETEROL; TERBUTALINE; THEOPHYLLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZAFIRLUKAST;

EID: 56149115952     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152808785107624     Document Type: Review
Times cited : (7)

References (144)
  • 11
    • 35648943236 scopus 로고    scopus 로고
    • Ying, S.; Zhang, G.; Gu, S.; Zhao, J. Cell Mol. Immunol., 2006, 3, 321.
    • Ying, S.; Zhang, G.; Gu, S.; Zhao, J. Cell Mol. Immunol., 2006, 3, 321.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.